CorVel Quarterly Earnings: Revenue, Net Income and Diluted EPS All Rise Year Over Year

Bottom line

- For the three-month reporting period covered by this filing, Earnings Per Share, Diluted was higher than the prior-year comparative, moving within a profit-to-profit transition. - For the same window, Net Income (Loss) Attributable to Parent was higher than the prior-year comparative, also moving within a profit-to-profit transition. - For the same window, Revenue from Contract with Customer, Excluding Assessed Tax was higher than the prior-year comparative. - For the same window, Revenues (the second reported revenue line tied to the same comparative structure) was also higher than the prior-year comparative. - The dual revenue reporting lines — Revenue from Contract with Customer, Excluding Assessed Tax and Revenues — both show a year-over-year increase at the top line for the three-month reporting period. - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

Reporting-period identity and source scope: the filing is the interim quarterly report on Form 10-Q for period-ended-2026-06-30 filed by CORVEL CORP (CIK 0000874866, ticker CRVL), under accession 0001193125-26-338216. The financial statements cover the three-month reporting period ended the three months ended June 30, 2026, with the prior-year comparative ended the three months ended June 30, 2025.

- This is the unaudited interim disclosure under SEC rules, prepared on a basis consistent with the audited consolidated financial statements for the latest fiscal year ended in March and referenced in Note 1 — Summary of Significant Accounting Policies. - The current-period numbers rest on the consolidated accounts of the Company and its subsidiaries, per the Basis of Presentation language in Note 1. - Per-share figures tie to the earnings-per-share disclosure framework described in Note 5 — Weighted Average Shares and Net Income Per Share. - Top-line figures tie to the revenue recognition framework described in Note 2 – Revenue Recognition. - Other Items referenced for orientation include Item 1 (Legal Proceedings), Item 1A (Risk Factors), Item 2 (Unregistered Sales of Equity Securities and Use of Proceeds), Item 3 (Quantitative and Qualitative Disclosures About Market Risk), Item 4 (Controls and Procedures and Legal Proceedings under Part II), Item 5 (Other Information), and Item 6 (Exhibits and Signatures). - Treasury stock activity referenced for orientation is described in Note 4 — Treasury Stock, and stock-based compensation in Note 3 — Stock-Based Compensation and Stock Options. - Legal contingencies referenced for orientation are described in Note 6 — Contingencies and Legal Proceedings. - Securities-registration class information and exchange-listing data are anchored in Section 12 of the Securities Exchange Act, and the filer-status representation is anchored in Section 13 of that Act.

Scope is strictly this single filing: the answer above reflects only what the three-month reporting period versus the prior-year three-month comparative reveals at the top of the income statement, with no analyst inference, no margin commentary, and no extrapolation to other periods. Readers seeking to test the per-share relationship against a model can confirm the absolute values with the ROI Calculator tool, used here only as a calculation reference and not as a recommendation.

Financial performance

- Top-line growth remains the headline story for the three-month reporting period of CORVEL CORP (CRVL), filed under 10-Q for period-ended-2026-06-30 and accessed at 0001193125-26-338216. Revenue from Contract with Customer, Excluding Assessed Tax was $259,925,000 USD for the three-month reporting period the three months ended June 30, 2026, higher than the prior-year figure of $234,711,000 USD for the three months ended June 30, 2025. The legacy Revenues line — preserved in Note 2's revenue-recognition discussion — likewise moved from $234,711,000 USD in the prior-year window to $259,925,000 USD in the current window, consistent with the authorized direction of increase.

The filing evidence does not attribute this change to any single cause. - Profitability tracked the same upward path. Net Income (Loss) Attributable to Parent was $32,225,000 USD for the three months ended June 30, 2026, an increase over the $27,235,000 USD reported for the three months ended June 30, 2025, with the authorized transition described as profit to profit.

52 per diluted share USD/SHARES for the prior-year period, again framed as a profit-to-profit comparison moving higher. The filing evidence does not attribute this change to any single cause. - The accounting backdrop is shaped by the single reportable operating segment — managed care — disclosed in Note 2.

That note explains how patient management revenue is recognized over time as performance obligations are satisfied, while network solutions revenue is recognized when control of the promised services transfers to customers. The typical contract term spans one year, most contracts auto-renew, and accounts receivable are generally expected to be collected within a short window disclosed elsewhere in the filing, although the precise days-billed range is not surfaced here. Those policy choices remain the lens through which the headline revenue figure should be read.

- Forward-looking accounting items are flagged rather than quantified. The filing notes that management is evaluating several recent ASUs — covering internal-use software capitalization, the measurement of credit losses on receivables and contract assets, and expense disaggregation disclosures — and that the credit-losses standard was already adopted prospectively in the first quarter of the referenced fiscal year without a material impact on the consolidated financial statements. The filing evidence does not attribute this change to any single cause.

- No segment breakout, geographic split, or contract-by-contract detail is provided for the quarter, so the period's revenue mix between patient management and network solutions cannot be derived from the filing evidence. Peer benchmarks and industry-wide checks are also absent from the filing text. The filing evidence contains no peer or industry comparison.

Readers building a forward-looking return view can still frame the comparison with a tool such as the ROI Calculator, since the period's authorization is limited to confirming the authorized direction of increase across revenue, net income and diluted EPS — not to assigning a cause.

Operating drivers and segments

The Company states that it operates in one reportable operating segment — managed care — so no segment table is presented in the filing (Note 2). That single-segment posture means the segment dimension cannot be used to triangulate the consolidated top line; whatever moved $234,711,000 and $259,925,000 — and the alternate revenue line showing $234,711,000 and $259,925,000 — has to be read against Company-wide service-mix and pricing evidence, which the quoted note disclosure does not break out for the three-month reporting period ending the three months ended June 30, 2026.

Management’s narrative in Note 1 frames the quarter as ordinary-course interim reporting: unaudited statements prepared under SEC rules, presumed familiarity with the March year-end audited statements, all adjustments deemed necessary for fair presentation included, and subsequent events evaluated through the filing date. Management also flags that the three-month result for the three months ended June 30, 2026 is not necessarily indicative of results for the fiscal year ending March (the next fiscal year-end). On the policy front, Management describes two open evaluations rather than recorded effects: a recent ASU on internal-use software capitalization (a principles-based replacement of the stage framework) and a practical-expedient ASU on credit-loss measurement for receivables and contract assets, both pending adoption for fiscal years beginning after a stated cut-off. Management offers no revenue-driver commentary, no service-line color, no claims-cost commentary, and no customer concentration narrative for the three months ended June 30, 2026 versus the three months ended June 30, 2025.

The consolidated income statement, however, shows that the two reported revenue lines moved in the same authorized direction — higher than the prior period — across both the contract-with-customers line ($259,925,000 versus $234,711,000) and the revenues line ($259,925,000 versus $234,711,000). Because the filing does not provide cost-of-services, expense-mix, or claim-volume disaggregation for the managed-care segment, the operating-leverage and margin-pressure dimensions cannot be read from the filing evidence for this section. The filing evidence does not attribute this change to any single cause.

Counter-evidence within the same filing is limited but worth noting: the ASU on expense disaggregation would, if adopted, force future disclosure of inventory purchases, employee compensation, and depreciation and amortization, implying that current disclosure is not at that granularity; and the credit-loss practical expedient assumes static conditions over the receivable’s life, which limits forward-looking expected-loss transparency. Neither item contradicts Management’s narrative for the three months ended June 30, 2026, but both narrow what an outside reader can independently verify about operating drivers today.

Independent analysis: with segment count fixed at one, no disaggregated expense disclosure, and no management-supplied driver commentary, the only analytically usable statements for this section are the two authorized revenue comparisons noted above. Everything that would normally sit beneath the revenue line — unit volume, price/mix, claims severity, employee-cost trend, technology capitalization choices — is either The filing evidence does not attribute this change to any single cause. in the quoted evidence or not addressed at all.

Cash flow and capital

The three-month operating cash flow was a positive inflow, while the prior-year comparative window also produced a positive operating inflow; on the authorized year-over-year basis the operating figure registered a decrease, with the prior period being the larger contributor. The investing line for the current period was a use of cash, and the prior-year investing line was likewise a use of cash; on the authorized year-over-year basis the investing outflow decreased, meaning a smaller deployment of cash into investing activities than the prior comparison. Financing for the current quarter was a use of cash, mirroring the prior-year financing outcome of a use of cash; on the authorized year-over-year basis the financing outflow decreased, indicating less cash returned through financing channels than in the prior comparison.

Capital expenditure is captured inside the investing line as payments to acquire property, plant, and equipment; both the current quarter and the prior-year quarter reflect positive cash outflows for that purpose, and on the authorized year-over-year basis capital expenditures decreased relative to the prior comparison. Share repurchases are captured inside financing as payments for repurchase of common stock; both the current quarter and the prior-year quarter reflect positive cash outflows for buybacks, and on the authorized year-over-year basis repurchase spending increased. The treasury-stock disclosure in the cited note describes the Board's authorization framework that permits these repurchases, and the payments line shows how much of that authorization was exercised during each window.

The balance sheet as of the period-end shows cash and cash equivalents at carrying value, accounts receivable net of the allowance for credit loss in the current section, and accounts payable in the current section. Working capital therefore includes a receivable base consistent with the Company's revenue recognition policy described in the cited revenue note — billed and unbilled receivables arise from services already transferred to customers, with substantially all unbilled revenues billed within one year. The payables balance represents obligations in the normal course that the cash position can service.

The combined picture is that operating activities continued to generate cash, but at a smaller scale than the prior-year comparison; investing absorbed less cash than the comparison period; financing returned less cash to shareholders and other financing counterparties overall; within financing, however, the Company returned more cash specifically through share repurchases than it did a year earlier, while investing absorbed less for property, plant and equipment. Net of all three lines, the cash and equivalents position at period-end reflects the residual of these flows. The filing evidence does not attribute this change to any single cause.

Peer and historical context

- Reading the three-month reporting period against the prior-year comparative for the same three-month window, CORVEL CORP (CRVL, per 10-Q for period-ended-2026-06-30, accession 0001193125-26-338216) shows the established revenue, earnings, and operating-cash profile that the company's own filings invite readers to use as the historical benchmark in this section. - Revenue from Contract with Customer, Excluding Assessed Tax moved higher year over year, with the current quarter's $259,925,000 USD exceeding the prior-year $234,711,000 USD for the same three-month period.

The legacy "Revenues" line tells the same story: $259,925,000 USD for the current quarter versus the prior-year $234,711,000 USD, both reported as positive amounts. The cited note on revenue recognition describes the underlying portfolio of fixed-fee claims management and patient management services that produced those amounts, with performance obligations typically satisfied within one year. - Net Income Attributable to Parent also moved higher year over year, and remained a profit on both windows: the current-quarter $32,225,000 USD is a profit, and the prior-year $27,235,000 USD was likewise a profit.

The authorized transition is profit to profit, and the authorized direction is increase. - Net Cash Provided by Operating Activities moved lower year over year, even though both periods remained positive cash generators: the current-quarter $49,921,000 USD is lower than the prior-year $55,011,000 USD. The authorized direction is decrease, and the authorized transition is positive to positive.

- Operating cash flow is still healthy enough to fund investing and financing activity, including the repurchase program disclosed in Note 4 and the equity-incentive transition described in Note 3, where the legacy Omnibus Plan expired and the replacement SIP now governs share availability and grant terms. - No peer-group, industry-index, or competitor-level figures are quoted anywhere in the filing evidence for this filing. The filing evidence contains no peer or industry comparison.

- No segment-level revenue, margin, or volume breakdown is offered for this dimension. The filing evidence does not disclose segment-level detail for this dimension. - The filing evidence does not attribute the operating-cash decline, the bottom-line gain, or the revenue growth to any single cause.

The filing evidence does not attribute this change to any single cause. - Readers modelling the year-over-year swing can frame the operating-cash and earnings moves with ROI Calculator when translating the figures into a return view, while keeping in mind that the calculator is a mechanical tool and is not itself a peer benchmark.

Scenario analysis

For CORVEL CORP (CRVL), the base case for the three months ended June 30, 2026 is the continuation of the actual reporting period's trajectory. Revenue from Contract with Customer, Excluding Assessed Tax reached $259,925,000 USD, the higher reading versus $234,711,000 USD for the three months ended June 30, 2025 under the authorized increase relation. Net Income (Loss) Attributable to Parent climbed to $32,225,000 USD against $27,235,000 USD in the prior-year window, holding the profit-to-profit transition with a higher directional move. The companion Revenues line — $259,925,000 USD against $234,711,000 USD — carries the same upward direction. The filing evidence does not attribute this change to any single cause. The base case assumes the revenue and earnings momentum visible in the filing extends into the next reporting period without the upside catalysts landing or the downside risks materializing.

The upside path would require the higher revenue print — $259,925,000 USD against $234,711,000 USD — to compound, paired with an acceleration in the Net Income (Loss) Attributable to Parent line to $32,225,000 USD versus $27,235,000 USD. The Revenues aggregate would similarly need to keep expanding off $259,925,000 USD versus $234,711,000 USD. Cited contingencies discussed in the cited contingencies note and the cited stock-based compensation note leave room for both earnings expansion and dilution mechanics; readers can frame the reinvestment math with the ROI Calculator before extrapolating the print. The filing evidence does not attribute this change to any single cause.

The downside case would see the upside in Revenue from Contract with Customer, Excluding Assessed Tax — $259,925,000 USD versus $234,711,000 USD — stall, with the corresponding Net Income (Loss) Attributable to Parent expansion to $32,225,000 USD versus $27,235,000 USD narrowing on a sequential basis. Revenues measured as $259,925,000 USD versus $234,711,000 USD would similarly lose pace. The cited treasury stock and contingencies disclosures flag share-repurchase mechanics and pending matters whose timing could pressure future earnings translation. The filing evidence does not attribute this change to any single cause.

Across all three scenarios, The filing evidence contains no peer or industry comparison. and The filing evidence does not disclose segment-level detail for this dimension. Readers should weight the directional moves — authorized increase on revenue, authorized increase on net income, authorized increase on Revenues, all profit-to-profit — without leaning on cause narratives the filing does not supply.

Risks and what to watch

- Reported facts: The three-month reporting period under 10-Q for CORVEL CORP (CRVL) shows Net Income (Loss) Attributable to Parent of $32,225,000 for the three months ended June 30, 2026, against $27,235,000 for the three months ended June 30, 2025. Revenue from Contract with Customer, Excluding Assessed Tax is $259,925,000 for the three months ended June 30, 2026 versus $234,711,000 for the three months ended June 30, 2025. Revenues, as separately captioned, is $259,925,000 for the three months ended June 30, 2026 versus $234,711,000 for the three months ended June 30, 2025.

Per the reported comparison set, both revenue captions and net income moved higher year over year, with net income remaining a profit in both windows (profit to profit). - Management explanations: The cited treasury-stock note describes the repurchase program as discretionary, without an obligation to acquire any amount, and funded primarily by company net income and stock-option exercise proceeds, while the cited contingencies note states that, although results cannot be predicted with certainty, the Company believes it is not currently a party to any legal proceedings, disputes, or other claims for which a material loss is considered probable and for which the amount (or range) of loss is reasonably estimable.

The cited stock-based compensation note describes grants as a mix of time-based and performance-based options, with expense on performance-based grants recognized only to the extent the earnings-per-share targets are probable. - Analyst inference: The filing evidence does not attribute this change to any single cause.. The mix between the two revenue captions is reconcilable only inside the cited revenue-recognition note, and the ledger does not link the higher revenue lines to any cost, mix, or pricing item, so no driver story is offered here.

- Counter-evidence and limits to the favorable read: The cited contingencies language ("cannot be predicted with certainty") and the discretionary framing of the repurchase program together leave open the possibility of negative items whose size is not presently estimable, even as no probable material loss is asserted today. The performance-based option expense recognition clause means that target-driven cost could appear in future periods if probability reassessment occurs, an item the filing does not quantify. Any peer or industry context for the revenue and net-income direction is absent, so the directional read cannot be benchmarked: The filing evidence contains no peer or industry comparison..

The filing also does not break out performance at the segment level beyond what the cited revenue-recognition note discloses, so any unit-level inference would be unsupported: The filing evidence does not disclose segment-level detail for this dimension.. - Unknowns: Whether the increase in revenue is broad-based across service lines, whether the higher net income benefited from a lower tax rate, share count, or operating margin, and the size and term of any post-period repurchases, all remain unstated in the quoted evidence.

- Metrics to watch next period: the same four lines — Net Income (Loss) Attributable to Parent under both captions of revenue and the per-share result — for their continued direction and for any change in the contingencies disclosure or in the probability assessment of the performance-based option targets. Readers modeling the return profile can cross-check assumptions with the ROI Calculator.